Simple jQuery Dropdowns

Browsing by Author Ting Liu

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)
1-May-2019Alectinib versus crizotinib in untreated Asian patients with anaplastic lymphoma kinase-positive non-small-cell lung cancer (ALESIA): a randomised phase 3 studyCaicun Zhou; Sang We Kim; Thanyanan Reungwetwattana; Jianying Zhou; Yiping Zhang; Jianxing He; Jin Ji Yang; Ying Cheng; Se Hoon Lee; Lilian Bu; Tingting Xu; Li Yang; Chao Wang; Ting Liu; Peter N. Morcos; You Lu; Li Zhang; Sun Yat-Sen University Cancer Center; Tongji University; Zhejiang Cancer Hospital; West China School of Medicine/West China Hospital of Sichuan University; Guangdong General Hospital; Asan Medical Center; SungKyunKwan University, School of Medicine; Faculty of Medicine, Ramathibodi Hospital, Mahidol University; Guangzhou Medical University; F. Hoffmann-La Roche AG; Zhejiang University; Roche Innovation Center; Jilin Cancer Hospital; Roche Pharma Development
5-Jun-2017Association between bortezomib dose intensity and overall survival in mantle cell lymphoma patients on frontline VR-CAP in the phase 3 LYM-3002 study<sup>*</sup>Tadeusz Robak; Huiqiang Huang; Jie Jin; Jun Zhu; Ting Liu; Olga Samoilova; Halyna Pylypenko; Gregor Verhoef; Noppadol Siritanaratkul; Evgenii Osmanov; Juliana Pereira; Jiri Mayer; Xiaonan Hong; Rumiko Okamoto; Lixia Pei; Brendan Rooney; Helgi van de Velde; Franco Cavalli; Medical University of Lodz; Sun Yat-Sen University Cancer Center; Zhejiang University School of Medicine; Beijing Cancer Hospital; West China Hospital of Sichuan University; Lobachevsky State University of Nizhni Novgorod; null; KU Leuven– University Hospital Leuven; Mahidol University; N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences; Universidade de Sao Paulo - USP; Fakultni Nemocnice Brno; Fudan University Shanghai Cancer Center; Tokyo Metropolitan Komagome Hospital; Janssen; Janssen Research and Development; Takeda Oncology; Ospedale San Giovanni
5-Mar-2015Bortezomib-based therapy for newly diagnosed mantle-cell lymphomaTadeusz Robak; Huiqiang Huang; Jie Jin; Jun Zhu; Ting Liu; Olga Samoilova; Halyna Pylypenko; Gregor Verhoef; Noppadol Siritanaratkul; Evgenii Osmanov; Julia Alexeeva; Juliana Pereira; Johannes Drach; Jiri Mayer; Xiaonan Hong; Rumiko Okamoto; Lixia Pei; Brendan Rooney; Helgi Van De Velde; Franco Cavalli; Medical University of Lodz; Sun Yat-Sen University Cancer Center; Zhejiang University School of Medicine; Beijing Cancer Hospital; West China Hospital of Sichuan University; Fudan University Shanghai Cancer Center; Nizhny Novgorod Regional Hospital; N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences; Federal Center of Heart; Cherkassy Regional Oncology Center; KU Leuven– University Hospital Leuven; Janssen Research and Development; Mahidol University; Universidade de Sao Paulo - USP; Medizinische Universitat Wien; Fakultni Nemocnice Brno; Tokyo Metropolitan Komagome Hospital; Janssen; Janssen Research and Development; Ospedale San Giovanni